A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1992
12/29/1992	CA1312086C Benzoquinone derivatives, their production and use
12/29/1992	CA1312085C2 Dihydropiridine compounds having unique pharmacological effects, and the process for producing them
12/29/1992	CA1312084C 1,3-dioxan-5-xl alkanoic acid derivatives
12/29/1992	CA1312083C Hydantoin derivatives
12/29/1992	CA1312082C Use of hydroquinolines for the treatment of cerebrovascular disorders
12/29/1992	CA1312081C Process for the manufacture of substituted pyrrolidinones
12/29/1992	CA1312080C Arylpiperazinyl-ethyl(or butyl)-phenyl-heterocyclic compounds
12/29/1992	CA1312079C Antimicrobial aromatic derivatives substituted by a (omega amino) alkanol group, process for their obtention and compositions containing them
12/29/1992	CA1312078C Indolylpropanols, processes for their preparation and their use, and preparations containing the compounds
12/29/1992	CA1312077C Process for preparing 1,5-benzothiazepine derivatives
12/29/1992	CA1312076C2 Prodrugs of rapamycin
12/29/1992	CA1312074C Epipodophyllotoxin glucoside 4'-acyl derivatives
12/29/1992	CA1312016C Osmotic continuous dispensing oral delivery system containing a moderately water-soluble metoprolol salt having improved core composition and use thereof
12/29/1992	CA1312015C Antiparkinson ergoline derivatives
12/29/1992	CA1312014C Cathartics containing prostaglandin derivatives
12/29/1992	CA1312013C Compositions and methods for treating gastrointestinal disorders
12/29/1992	CA1312012C Compositions and methods for treating gastrointestinal disorders
12/29/1992	CA1312011C Concentrated stable fluorochemical aqueous emulsions
12/29/1992	CA1312010C Stable fluorochemical aqueous emulsions
12/28/1992	WO1993000334A1 Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
12/28/1992	CA2090240A1 Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
12/28/1992	CA2072528A1 4-pyrimidinecarboxamide derivatives, their preparation and their application in therapy
12/28/1992	CA2072520A1 2-(1-piperidyl) ethanol derivatives, their preparation and their therapeutic application
12/28/1992	CA2072433A1 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
12/28/1992	CA2072227A1 2-(3-substituted phenylhydrazino)-2-thiazolines and 2-(3-substituted phenylazo)-2-thiazolines, their preparation, and their use for combating ectoparasites
12/28/1992	CA2072217A1 2-(4-substituted phenylhydrazino)-2-thiazolines and 2-(4-substituted phenylazo)-2-thiazolines, their preparation, and their use for combating ectoparasites
12/28/1992	CA2072207A1 7-azaisoindolinyl-quinolone-and-naphthyridonecarboxylic- acid derivatives
12/27/1992	WO1993000057A1 Transdermal nicotine absorption dosage unit and process
12/27/1992	CA2094913A1 Transdermal nicotine absorption dosage unit and process
12/27/1992	CA2072303A1 Inositol phosphate analogues as calcium-antagonistic substances
12/27/1992	CA2071574A1 Process for the glycosylation of avermectin compounds
12/26/1992	WO1993000350A1 METHOD OF EXTRACTING SENNOSIDES A, B and A1
12/26/1992	WO1993000322A1 Method of preparing diacetyl rhein
12/26/1992	CA2072215A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents
12/26/1992	CA2072031A1 Cephalosporins having a 2-thia cephem nucleus, method of preparation, their use as therapeutic agents, pharmaceutical compositions containing them and new intermediaries obtained
12/26/1992	CA2071439A1 2-heteroarylphenyl-carbapenem antibacterial agents
12/26/1992	CA2071332A1 C-21 hydroxylated fk-506 antagonist
12/26/1992	CA2071086A1 Heterocyclic compounds
12/26/1992	CA2071021A1 Heterocyclic derivatives
12/25/1992	CA2072293A1 Alkylthiopoly (ethylimidazolium) coumpounds, process for their preparation, and their use as biocides
12/25/1992	CA2072282A1 Polyfluoroalkylthiopoly(ethylimidazolium) compounds, process for their preparation, and their use as biocides
12/25/1992	CA2071800A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
12/25/1992	CA2071793A1 Imidazole compounds, their preparation and use
12/23/1992	WO1992022819A1 Diagnosis and treatment of arterial chlamydial granuloma
12/23/1992	WO1992022662A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures
12/23/1992	WO1992022661A1 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
12/23/1992	WO1992022651A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	WO1992022588A1 Acylated heparins as inhibitors of the replication of retroviruses
12/23/1992	WO1992022585A1 Methods of treating hemorrhoids and anorectal disease
12/23/1992	WO1992022565A1 Modified sialyl lewisx compounds
12/23/1992	WO1992022564A1 Immunosuppressive and tolerogenic modified lewisx and lewisa compounds
12/23/1992	WO1992022563A1 Modified sialyl lewisa compounds
12/23/1992	WO1992022559A1 Dialkyl (dialkoxyphosphinyl)methyl phosphates as anti-inflammatory agents
12/23/1992	WO1992022556A1 Novel 3-fused pyridiniummethyl cephalosporins
12/23/1992	WO1992022554A1 Piperidine derivates having anxiolytic effect
12/23/1992	WO1992022553A1 IMIDAZO[1,2-a](PYRROLO, THIENO OR FURANO)[3,2-d]AZEPINE DERIVATIVES, COMPOSITIONS AND METHODS OF USE
12/23/1992	WO1992022552A1 IMIDAZO[1,5-a]QUINOXALINES
12/23/1992	WO1992022551A1 IMIDAZO[2,1-b][3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE
12/23/1992	WO1992022550A1 Azaspiro quinolone antibacterial agents
12/23/1992	WO1992022543A1 N-hydroxyurea derivatives which inhibit lipoxygenase
12/23/1992	WO1992022542A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use
12/23/1992	WO1992022541A1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, their preparation and their use
12/23/1992	WO1992022540A1 Aminoalkyl-substituted 5-mercaptothiazoles, their preparation and their use
12/23/1992	WO1992022539A1 Aminoalkyl-substituted thiazolin-2-ones, their preparation and their use
12/23/1992	WO1992022537A1 New selective aromatase inhibiting 4(5)-imidazoles
12/23/1992	WO1992022534A1 Alzheimer's disease treatment with tacrine metabolites
12/23/1992	WO1992022533A1 4-aminoquinolines and pharmaceutical compositions thereof
12/23/1992	WO1992022527A2 3-substituted pyrrolidine derivatives as calcium channel antagonists
12/23/1992	WO1992022520A1 Orally active antiviral compounds
12/23/1992	WO1992022334A1 Platelet receptor antagonists useful in detecting intravascular platelet aggregation
12/23/1992	WO1992022312A1 Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
12/23/1992	WO1992022303A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
12/23/1992	WO1992022302A1 Treatment of human diseases involving dysregulation or dysfunction of the nervous system
12/23/1992	WO1992022301A1 Immunosuppressive and tolerogenic oligosaccharide derivatives
12/23/1992	WO1992022300A1 Ocular compositions containing steroids and their use in treating glaucoma
12/23/1992	WO1992022298A1 Novel liposomal drug delivery systems
12/23/1992	WO1992022297A1 New compounds and compositions useful as antifungal and antimycobacterial agents
12/23/1992	WO1992022296A1 Use of atipamezole for the treatment of male sexual impotence
12/23/1992	WO1992022295A1 Use of guanidine derivatives in the preparation of a drug for the treatment of sepsis and sepsis-like conditions and septic shock
12/23/1992	WO1992022294A1 Immunomodulatory azaspiranes
12/23/1992	WO1992022293A1 Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
12/23/1992	WO1992022292A1 Nitroglycerine plaster and process for making it
12/23/1992	WO1992022290A1 Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins
12/23/1992	WO1992022289A1 Novel phospholipase a2 inhibitors
12/23/1992	WO1992022288A1 Non-chlorofluorocarbon aerosol formulations
12/23/1992	WO1992022287A1 Non-chlorofluorocarbon aerosol formulations
12/23/1992	WO1992022286A1 Albuterol sulfate suspension aerosol formulations
12/23/1992	WO1992022284A1 Oral-administration forms of a medicament containing pantoprazol
12/23/1992	WO1992019227A3 Pharmaceutical formulations
12/23/1992	WO1992019224A3 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative
12/23/1992	WO1992016612A3 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
12/23/1992	EP0519870A1 New oral diclofenac composition
12/23/1992	EP0519831A1 N-Substituted heterocyclic derivatives, their preparation, and pharmaceutical compositions containing them
12/23/1992	EP0519820A1 Matrixtablet for the sustained release of indapamide after oral administration
12/23/1992	EP0519819A1 Composition for use to reduce hair loss and to induce and stimulate its growth, containing derivatives of 2,4,6-triaminopyrimidin-N-oxide and the new derivatives of 2,4,6-triaminopyrimidin-N-oxide
12/23/1992	EP0519731A1 4a-Substituted avermectin derivatives
12/23/1992	EP0519702A1 Orally active antiviral compounds
12/23/1992	EP0519678A2 1,4-Benzodiazepines with 6-membered heterocyclic rings
12/23/1992	EP0519673A1 Composition containing dioxabicyclo[3.3.0]octane derivative
12/23/1992	EP0519602A1 Use of a dihydrothienopyridine-derivative for inhibiting the release of cerebral glutamate

1 ... 7224 7225 7226 7227 7228 7229 7230 7231 7232 7233 7234 7235 7236 7237 7238 7239 7240 7241 7242 7243 7244 ... 7860